These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10523693)

  • 1. Mutational alteration of the p16CDKN2a tumor suppressor gene is infrequent in Ewing's sarcoma.
    Park YK; Chi SG; Kim YW; Park HR; Unni KK
    Oncol Rep; 1999; 6(6):1261-6. PubMed ID: 10523693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low incidence of genetic alterations of the p16CDKN2a in clear cell chondrosarcoma.
    Park YK; Cho CH; Chi SG; Han CS; Ushigome S; Unni KK
    Int J Oncol; 2001 Oct; 19(4):749-53. PubMed ID: 11562750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational alterations of the p16CDKN2A tumor suppressor gene have low incidence in mesenchymal chondrosarcoma.
    Bae DK; Park YK; Chi SG; Lee CW; Unni KK
    Oncol Res; 2000; 12(1):5-10. PubMed ID: 11061340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 mutations in Ewing's sarcoma.
    Park YK; Chi SG; Kim YW; Park HR; Unni KK
    Oncol Rep; 2001; 8(3):533-7. PubMed ID: 11295075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and ras mutations in Ewing's sarcoma.
    Radig K; Schneider-Stock R; Röse I; Mittler U; Oda Y; Roessner A
    Pathol Res Pract; 1998; 194(3):157-62. PubMed ID: 9587933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced or absent expression and codon 201Gly/Arg polymorphism of DCC gene in rhabdomyosarcoma and Ewing's sarcoma/PNET family.
    Choi SH; Kong XT; Taki T; Tsuchida Y; Kawaguchi H; Kato H; Hanada R; Look AT; Hayashi Y
    Int J Mol Med; 2000 Oct; 6(4):463-7. PubMed ID: 10998440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 and CDK4 gene amplification in Ewing's sarcoma.
    Ladanyi M; Lewis R; Jhanwar SC; Gerald W; Huvos AG; Healey JH
    J Pathol; 1995 Feb; 175(2):211-7. PubMed ID: 7738717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1.
    Lu Q; Lu M; Li D; Zhang S
    Mol Med Rep; 2018 Oct; 18(4):3577-3588. PubMed ID: 30106161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas.
    Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T
    Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Bcl10 gene mutations in Ewing's sarcomas.
    Park YK; Chi SG; Unni KK
    Oncol Rep; 2001; 8(6):1333-5. PubMed ID: 11605060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
    Kinsey M; Smith R; Lessnick SL
    Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
    Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
    J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ewing's sarcoma: analysis of single nucleotide polymorphism in the EWS gene.
    Silva DS; Sawitzki FR; De Toni EC; Graebin P; Picanco JB; Abujamra AL; de Farias CB; Roesler R; Brunetto AL; Alho CS
    Gene; 2012 Nov; 509(2):263-6. PubMed ID: 22925827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT.
    Brownhill SC; Taylor C; Burchill SA
    Br J Cancer; 2007 Jun; 96(12):1914-23. PubMed ID: 17533400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ewing's Sarcoma: An Analysis of miRNA Expression Profiles and Target Genes in Paraffin-Embedded Primary Tumor Tissue.
    Parafioriti A; Bason C; Armiraglio E; Calciano L; Daolio PA; Berardocco M; Di Bernardo A; Colosimo A; Luksch R; Berardi AC
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
    Haga A; Ogawara Y; Kubota D; Kitabayashi I; Murakami Y; Kondo T
    Electrophoresis; 2013 Jun; 34(11):1670-8. PubMed ID: 23483572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
    Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
    Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.